Small Biotech, Device Companies Face Research Oversight Hurdles

October 24, 2018

Smaller drug and device companies will be more vulnerable to compliance pitfalls than industry giants like Pfizer and Johnson & Johnson when changes to the Department of Health and Human Services (HHS) research oversight regulations take effect in January.